Tilray | TRLY - Fremdkapital





Fremdkapital Veränderung Datum
Acasti Pharma USD 0 0 2024-12
Akebia Therapeutics USD 24.75M 11.64M 2026-06
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Aurora Cannabis CAD 18.13M 15.07M 2026-03
Avita Medical AUD 42.24M 1.25M 2024-12
Canopy Growth CAD 217.12M 7.87M 2026-03
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 50M 30M 2026-03
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
IQVIA Holdings USD 13.7B 284M 2026-06
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Moderna USD 597M 6M 2026-06
Organigram Holdings CAD 60.76M 1.77M 2026-03
Organon & Co USD 8.48B 74M 2026-06
Revvity USD 2.63B 1.02M 2026-06
Tectonic Therapeutic USD 17K 26K 2026-03
Tilray USD 268.59M 3.82M 2025-09
Viatris USD 11.61B 801.1M 2026-06
Xeris Pharmaceuticals USD 188.81M 32.42M 2026-06
Zealand Pharma A/S 307M 76.14M 2026-03